Antibiotic-induced neurological adverse drug reactions
Clémence Lacroix(Inserm), Joëlle Micallef(Institut de Neurosciences des Systèmes), Frank Rouby(Inserm), Romain Guilhaumou(Hôpital de la Timone), Tessa Pietri(Institut de Neurophysiopathologie), Vincent Montero(Centre National de la Recherche Scientifique), Olivier Blin(Inserm), Thomas Soeiro(Inserm)
Cited by 6
Related Papers
Use of proton pump inhibitors in adults in France: a nationwide drug utilization study
|European Journal of Clinical Pharmacology|2019|130
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Non-targeted screening for novel psychoactive substances among agitated emergency department patients
|Clinical Toxicology|2016|42